Dermapharm Holding Balance Sheet Health
Financial Health criteria checks 3/6
Dermapharm Holding has a total shareholder equity of €589.0M and total debt of €1.0B, which brings its debt-to-equity ratio to 174.1%. Its total assets and total liabilities are €2.1B and €1.5B respectively. Dermapharm Holding's EBIT is €214.4M making its interest coverage ratio 4.5. It has cash and short-term investments of €118.6M.
Key information
174.1%
Debt to equity ratio
€1.03b
Debt
| Interest coverage ratio | 4.5x |
| Cash | €118.57m |
| Equity | €589.04m |
| Total liabilities | €1.53b |
| Total assets | €2.12b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DMP's short term assets (€623.1M) exceed its short term liabilities (€374.9M).
Long Term Liabilities: DMP's short term assets (€623.1M) do not cover its long term liabilities (€1.2B).
Debt to Equity History and Analysis
Debt Level: DMP's net debt to equity ratio (154%) is considered high.
Reducing Debt: DMP's debt to equity ratio has reduced from 198.4% to 174.1% over the past 5 years.
Debt Coverage: DMP's debt is not well covered by operating cash flow (19.2%).
Interest Coverage: DMP's interest payments on its debt are well covered by EBIT (4.5x coverage).